Filter Search for grants
Call Navigation
Call key data
Advancing promising results from Pillar II collaborative research through the innovation journey
Funding Program
Horizon Europe
Call number
HORIZON-BRIDGING-2027-02-05
deadlines
Opening
20.10.2026
Deadline
28.01.2027 17:00
Funding rate
70% (NPO: 100%)
Call budget
€ 32,500,000.00
Estimated EU contribution per project
up to € 2,500,000.00
Link to the call
Link to the submission
Call content
short description
Projects funded under Horizon Europe’s Pillar II generate a wealth of high potential innovative results. Even though such results are many times successfully translated into used solutions, there is a need to increase the efficiency of the R&I investments and foster more uptake of promising results into innovative solutions. If more results were converted into innovative products, processes, services, practices, business models or other novel solutions, they would strongly contribute to European societal benefit, sustainable competitiveness, prosperity, clean transformation, wellbeing or strategic autonomy.
Call objectives
This topic aims at supporting actions that bring solutions generated by Pillar II closer to production and adoption by testing and validating them in real world settings, taking into consideration societal needs, cultural diversity and responsible innovation.
Consortia do not necessarily have to include beneficiaries from the previous grant(s) but must own or have access to the knowledge assets, including intellectual property, where relevant, as stipulated in the specific conditions of this topic. Applicants should justify the proposed composition of the consortium and how it brings the necessary expertise and results ownership. Proposals may also build on complementary background results from closely related EU actions or national/regional projects contributing to the same innovation pathway, provided that these complementary results strengthen the market-readiness and deployment potential of the main result of the Horizon Europe project.
Applicants should evidence that the proposed activities start beyond the laboratory or research environment and should focus on prototyping, testing, demonstrating, piloting, large-scale product validation and market replication under real-world conditions.
Proposals should focus on innovation activities that cover the later stages of development, including the use of research and technology infrastructures where relevant, should cover more than one of the following activities:
- Validation and Testing activities: This could include refining or piloting of prototypes through iterative testing, ensuring they meet the required regulatory or other standards before moving forward; testing to gain approval from potential users, or trial in real-world settings, including to understand user preferences and/or optimise outcomes; stress testing for technical feasibility to ensure the robustness of solutions at scale.
- Commercialisation aspects: This could include activities around regulatory compliance standardisation or certification, development of business or pricing strategies and planning for market entry.
- Scaling and Operations: This could include activities around large scale validation such as interoperability and/or standardising processes for quality assurance and control; preparations for supply chains and operational readiness; planning for ramping up manufacturing or delivery.
- Stakeholder, User and Market Readiness: This could include activities that involve engaging users/customers through co-creation and iterative feedback mechanisms to refine products and strategies, and to ensure that the proposed solutions are aligned with industrial and/or societal needs, concerns and expectations.
- Deployment and Investment Bridging: This could include partnering activities to expands market reach and securing the required investment commitment for the next phase by EU or national deployment programmes or investment funds.
Proposals should clearly outline which wider impact can be expected if the project succeeds, along with convincing Key Performance Indicators or a similar framework to measure and follow up the project impact. Impacts do not have to be only monetary but can also consist of other kinds of societal benefits and impacts on wellbeing, clean transformation, resilience or strategic autonomy etc. To assess the value for investment, proposals should specify, with metrics where relevant, all the following:
- Describe the expected scale and significance of the identified wider impacts.
- Include a business plan or exploitation strategy (including risks and mitigation) that will be further developed during the project. Proposals should identify the beneficiary(ies) (e.g. industry, company, public authority, etc.) responsible for the scaling-up of the solutions. The exploitation strategy should envisage a first deployment in the EU and/or Associated Countries.
- End users should be represented as a beneficiary within the consortium (and identified in the proposal) to test the feasibility of the solution and to ensure that the innovations developed meet the specific needs and requirements of the demand. To support the expected outcomes of the topic, additional end users beyond the project consortium can be subcontracted for further testing and validation activities.
If the activities to be carried out under the proposal are relevant and align with STEP eligibility, (i.e. digital and deep tech, clean and resource efficient tech and biotech) proposals should demonstrate how they contribute to either: i) bringing innovative, cutting-edge technologies with strong economic potential to the internal market, or ii) reducing or preventing the Union’s strategic dependencies.
Where relevant, applicants envisaging to include clinical studies should provide details of their clinical studies in the dedicated annex using the template provided in the submission system.
read more
Expected results
Project results are expected to contribute to all the following expected outcomes:
- Research and Innovation (R&I) solutions funded under Horizon Europe Pillar II are further advanced along the innovation pathway towards uptake and deployment in the EU and/or Associated Countries, including their translation into high value products, services, processes or business models, strengthening the capacity of European public and private organisations to use innovative solutions.
- End users and market actors actively co-develop and validate highly innovative solutions in real-world settings, ensuring demand-side needs are integrated, helping to de-risk the innovation journey.
- The EU and Associated Countries benefit from accelerated commercialisation, adoption and deployment of Horizon Europe results, thereby reinforcing societal benefits, sustainable competitiveness, resilience and strategic autonomy of the Union.
Eligibility Criteria
Regions / countries for funding
Faeroes (Føroyar / Færøerne), Israel (ישראל / إِسْرَائِيل), Kosovo (Kosova/Kosovë / Косово), Morocco (المغرب), Switzerland (Schweiz/Suisse/Svizzera), Tunisia (تونس /Tūnis), United Kingdom
eligible entities
EU Body, Education and training institution, Non-Profit Organisation (NPO) / Non-Governmental Organisation (NGO), Other, Private institution, incl. private company (private for profit), Public Body (national, regional and local; incl. EGTCs), Research Institution incl. University, Small and medium-sized enterprise (SME)
Mandatory partnership
Yes
Project Partnership
To be eligible for funding, applicants must be established in one of the following countries:
- the Member States of the European Union, including their outermost regions;
- the Overseas Countries and Territories (OCTs) linked to the Member States;
- countries associated to Horizon Europe; Albania, Arab Republic of Egypt, Armenia, Bosnia and Herzegovina, Canada, Faroe Islands, Georgia, Iceland, Israel, Kosovo, Moldova, Montenegro, New Zealand, North Macedonia, Norway, Republic of Korea, Serbia, Switzerland, Tunisia, Türkiye, Ukraine, United Kingdom;
- the following low- and middle-income countries: Afghanistan, Algeria, Angola, Argentina, Azerbaijan, Bangladesh, Belarus, Belize, Benin, Bhutan, Bolivia, Botswana, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Central African Republic, Chad, Colombia, Comoros, Congo (Democratic Republic), Congo (Republic), Costa Rica, Côte d'Ivoire, Cuba, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt (Arab Republic), El Salvador, Equatorial Guinea, Eritrea, Eswatini, Ethiopia, Fiji, Gabon, Gambia, Ghana, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Indonesia, Iran (Islamic Republic), Iraq, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Korea (Democratic People's Republic), Kyrgyz Republic, Lao (People’s Democratic Republic), Lebanon, Lesotho, Liberia, Libya, Madagascar, Malawi, Malaysia, Maldives, Mali, Marshall Islands, Mauritania, Mauritius, Micronesia (Federated States), Mongolia, Morocco, Mozambique, Myanmar, Namibia, Nepal, Nicaragua, Niger, Nigeria, Niue, Pakistan, Palau, Palestine, Papua New Guinea, Paraguay, Peru, Philippines, Rwanda, Samoa, São Tomé and Principe, Senegal, Sierra Leone, Solomon Islands, Somalia, South Africa, South Sudan, Sri Lanka, St. Lucia, St. Vincent and the Grenadines, Sudan, Suriname, Syrian Arab Republic, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Turkmenistan, Tuvalu, Uganda, Uzbekistan, Vanuatu, Venezuela (Bolivarian Republic), Vietnam, Yemen Republic, Zambia, Zimbabwe.
Legal entities which are established in countries not listed above will be eligible for funding if provided for in the specific call/topic conditions, or if their participation is considered essential for implementing the action by the granting authority.
Any legal entity, regardless of its place of establishment, including legal entities from non associated third countries or international organisations (including international European research organisations) is eligible to participate (whether it is eligible for funding or not), provided that the conditions laid down in the Horizon Europe Regulation have been met, along with any other conditions laid down in the specific call/topic.
A ‘legal entity’ means any natural or legal person created and recognised as such under national law, EU law or international law, which has legal personality and which may, acting in its own name, exercise rights and be subject to obligations, or an entity without legal personality.
Unless otherwise provided for in the specific call/topic conditions, only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows:
- at least one independent legal entity established in a Member State; and
- at least two other independent legal entities, each established in different Member States or Associated Countries.
As affiliated entities do not sign the grant agreement, they do not count towards the minimum eligibility criteria for consortium composition (if any).
Consortia may include a maximum of 6 independent eligible entities as participants.
Specific cases
Affiliated entities — Affiliated entities (i.e. entities with a legal or capital link to a beneficiary which participate in the action with similar rights and obligations to the beneficiaries, but which do not sign the grant agreement and therefore do not become beneficiaries themselves) are allowed, if they are eligible for participation and funding.
Associated partners — Associated partners (i.e. entities which participate in the action without signing the grant agreement, and without the right to charge costs or claim contributions) are allowed, subject to any specific call/topic conditions.
Entities without legal personality — Entities which do not have legal personality under their national law may exceptionally participate, provided that their representatives have the capacity to undertake legal obligations on their behalf, and offer guarantees to protect the EU’s financial interests equivalent to those offered by legal persons.
EU bodies — Legal entities created under EU law including decentralised agencies may be part of the consortium, unless provided for otherwise in their basic act.
International organisations — International European research organisations are eligible to receive funding. International organisations with headquarters in a Member State or Associated Country are eligible to receive funding for ‘Training and mobility’ actions or when provided for in the specific call/topic conditions. Other international organisations are not eligible to receive funding, unless provided for in the specific call/topic conditions, or if their participation is considered essential for implementing the action by the granting authority.
Joint Research Centre (‘JRC’) — Where provided for in the specific call/topic conditions, applicants may include in their proposals the possible contribution of the JRC, but the JRC will not participate in the preparation and submission of the proposal. Applicants will indicate the contribution that the JRC could bring to the project based on the scope of the topic text. After the evaluation process, the JRC and the consortium selected for funding may come to an agreement on the specific terms of the participation of the JRC. If an agreement is found, the JRC may accede to the grant agreement as beneficiary requesting zero funding or participate as an associated partner, and would accede to the consortium as a member.
Associations and interest groupings — Entities composed of members (e.g. European research infrastructure consortia (ERICs)) may participate as ‘sole beneficiaries’ or ‘beneficiaries without legal personality’. However, if the action is in practice implemented by the individual members, those members should also participate either as beneficiaries or as affiliated entities (otherwise their costs will NOT be eligible).
EU restrictive measures — Entities subject to EU restrictive measures under Article 29 of the Treaty on the European Union (TEU) and Article 215 of the Treaty on the Functioning of the EU (TFEU) as well as Article 75 TFEU, are not eligible to participate in any capacity, including as beneficiaries, affiliated entities, associated partners, third parties giving in-kind contributions, subcontractors or recipients of financial support to third parties (if any).
Legal entities established in Russia, Belarus, or in non-government controlled territories of Ukraine — Given the illegal invasion of Ukraine by Russia and the involvement of Belarus, there is currently no appropriate context allowing the implementation of the actions foreseen in this programme with legal entities established in Russia, Belarus, or in non-government controlled territories of Ukraine. Therefore, even where such entities are not subject to EU restrictive measures, such legal entities are not eligible to participate in any capacity. This includes participation as beneficiaries, affiliated entities, associated partners, third parties giving in-kind contributions, subcontractors or recipients of financial support to third parties (if any). Exceptions may be granted on a case-by-case basis for justified reasons.
With specific regard to measures addressed to Russia, following the adoption of the Council Regulation (EU) 2024/1745 of 24 June 2024 (amending Council Regulation (EU) No 833/2014 of 31 July 2014) concerning restrictive measures in view of Russia’s actions destabilising the situation in Ukraine, legal entities established outside Russia whose proprietary rights are directly or indirectly owned for more than 50% by a legal person, entity or body established in Russia are also not eligible to participate in any capacity.
Measures for the protection of the Union budget against breaches of the principles of the rule of law in Hungary — Following the Council Implementing Decision (EU) 2022/2506, as of 16 December 2022, no legal commitments can be entered into with Hungarian public interest trusts established under the Hungarian Act IX of 2021 or any entity they maintain. Affected entities may continue to apply to calls for proposals and can participate without receiving EU funding, as associated partners, if allowed by the call conditions. However, as long as the Council measures are not lifted, such entities are not eligible to participate in any funded role (beneficiaries, affiliated entities, subcontractors, recipients of financial support to third parties, etc.). In the case of multi-beneficiary grant calls, applicants will be invited to remove or replace that entity in any funded role and/or to change its status into associated partner. Tasks and budget may be redistributed accordingly.
Additional information
Topics
Relevance for EU Macro-Region
EUSAIR - EU Strategy for the Adriatic and Ionian Region, EUSALP - EU Strategy for the Alpine Space, EUSBSR - EU Strategy for the Baltic Sea Region, EUSDR - EU Strategy for the Danube Region
UN Sustainable Development Goals (UN-SDGs)
project duration
36 months
Additional Information
Applications must be submitted electronically via the Funders & Tenders Portal electronic submission system (accessible via the topic page in the Search Funding & Tenders section). Paper submissions are NOT possible.
Applications must be submitted using the forms provided inside the electronic submission system (not the templates available on the topic page, which are only for information). The structure and presentation must correspond to the instructions given in the forms.
Applications must be complete and contain all parts and mandatory annexes and supporting documents.
Applications must include a plan for the exploitation and dissemination of results including communication activities, unless provided otherwise in the specific call/topic conditions. The plan is not required for applications at the first stage of two-stage procedures. If the expected exploitation of the results entails developing, creating, manufacturing and marketing a product or process, or in creating and providing a service, the plan must include a strategy for such exploitation. If the plan provides for exploitation of the results primarily in non-associated third countries, the applicants must explain how that exploitation is to be considered in the EU’s interest.
The application form will have two parts:
- Part A (to be filled in directly online) contains administrative information about the applicant organisations (future coordinator and beneficiaries and affiliated entities), the summarised budget for the proposal and call-specific questions;
- Part B (to be downloaded from the Portal submission system, completed and then assembled and re-uploaded as a PDF in the system) contains the technical description of the project.
Annexes and supporting documents will be directly available in the submission system and must be uploaded as PDF files (or other formats allowed by the system).
The limit for a full application (Part B) is 45 pages.
The starting TRL for proposals based on results generated within a project funded under Cluster 3, 4, 5 or 6 should be TRL 6. For proposals based on results generated within a project funded under Cluster 1 or 2, the proposed activities must start beyond the laboratory or research environment and focus on prototyping, testing, demonstrating, piloting, large-scale product validation and market replication under real-world conditions. In case of proposals that are based on results generated within more than one projects, the Cluster of the primary project -as stated by the applicants in their proposal- will be the Cluster to be considered.
The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5.
Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025).
The proposals must be based on results generated within a prior multi beneficiary project funded directly under the Clusters of Pillar II (Clusters 1 to 6), through a Research and Innovation Action (RIA), an Innovation Action (IA) or a Pre-commercial Procurement Action (PCP). Applicants may submit a proposal based on results generated within more than one such projects (from the same or different Clusters of Pillar II), however only one of these projects will be considered as primary. Applicants must explicitly state in their proposal the project concerned (or the primary project concerned in case the proposal is based on results generated within more than one projects), by providing the relevant grant number and acronym as indicated in the Funding & Tenders Portal.
The project(s) must have been completed before the submission deadline. Ongoing projects are not considered eligible. Only projects where the granting authority for the completed project is the Commission or Executive Agency are eligible.
Proposals must provide evidence that the consortium owns or has access to the knowledge assets, including intellectual property, where relevant. More specifically, proposals must include at least one of the following:
- Confirmation that at least one of the applicants is the owner or holder of the relevant knowledge assets, including if applicable Intellectual Property Rights (IPR), and possesses the necessary rights to commercialise/use the results, or
- Commitment letter from the owner(s) of the relevant result(s) confirming the owner(s)’ willingness to negotiate fair, reasonable, and non-discriminatory access to the results, including IPR where relevant, for the purpose of future exploitation.
In line with the “restriction on control in innovation actions in critical technology areas” delineated in General Annex B of the General Annexes, entities established in an eligible country but which are directly or indirectly controlled by China or by a legal entity established in China are not eligible to participate in the action.
Some activities, resulting from this topic, may involve using classified background and/or producing of security sensitive results (EUCI and SEN). Please refer to the related provisions in section B Security — EU classified and sensitive information of the General Annexes.
The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold will be 12.
To allow a faster access to funds for small collaborative consortia, grants under this topic will be funded under a Fast Track to Research and Innovation Procedure (FTRI).
Indicative timetable for evaluation and grant agreement signature will be:
- Information on the outcome of the evaluation: Maximum 4 months from the final date for submission; and
- Indicative date for the signing of grant agreements: Maximum 6 months from the final date for submission.
To ensure a balanced project portfolio covering all Clusters of Pillar II (Clusters 1 to 6), grants will be awarded (within available budget) to proposals not only in order of ranking but at least also to those proposals that are the 2 highest ranked within different Clusters targeted, provided that the proposals attain all thresholds.
Eligible proposals submitted under this topic and exceeding all the evaluation thresholds will be awarded a STEP Seal.
Call documents
Horizon Europe Work Programme 2026-2027 Horizontal ActivitiesHorizon Europe Work Programme 2026-2027 Horizontal Activities(1262kB)
Contact

